SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-016456
Filing Date
2023-03-06
Accepted
2023-03-06 18:14:35
Documents
1
Period of Report
2023-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7026
  Complete submission text file 0001209191-23-016456.txt   8367
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 CORTLAND STREET, 16TH FLOOR NEW YORK NY 10007
Business Address
Murdock Hunter R. (Reporting) CIK: 0001934008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37635 | Film No.: 23710319